Navigation Links
InterMune Announces Conference Call and Webcast to Discuss Outcome of FDA Advisory Committee
Date:3/9/2010

BRISBANE, Calif., March 9 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: ITMN) announced that it will hold a webcast of a live conference call today at 5:00 p.m. EST to discuss the outcome of today's Pulmonary-Allergy Drugs Advisory Committee (PADAC).  The committee was convened by the U.S. Food and Drug Administration to review and discuss the company's New Drug Application (NDA) for pirfenidone for the treatment of patients with idiopathic pulmonary fibrosis (IPF).  

Conference Call and Webcast Details

Investors and media may participate in the conference call by dialing 888-799-0528 (U.S.) or 973-200-3372 (international), conference ID# 61659499.  A replay of the webcast and teleconference will be available approximately three hours after the call.

To access the webcast, please log on to the company's website at www.intermune.com at least 15 minutes prior to the start of the call to ensure adequate time for any software downloads that may be required.

The teleconference replay will be available for 10 business days following the call and can be accessed by dialing 800-642-1687 (U.S.) or 706-645-9291 (international), and entering the conference ID# 61659499.

SOURCE InterMune, Inc.

Back to top

RELATED LINKS
http://www.intermune.com

'/>"/>

SOURCE InterMune, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. InterMune Announces Approval of Clinical Trial Authorization for Phase 1b Trial of ITMN-191
2. InterMune Announces Start of Phase 1b Trial of ITMN-191
3. InterMune Announces Top-Line Results of Phase 1b Trial of ITMN-191 (R7227) and Provides Program Update
4. InterMune Provides Additional Information on ITMN-191 (R7227) MAD Study Results
5. InterMune Announces Progress on Pirfenidone in IPF
6. InterMune Announces Receipt of Fast Track Designation for Pirfenidone From FDA
7. InterMune Announces Start of 14-Day Triple Combination Study of ITMN-191 in Patients With Chronic Hepatitis C
8. Roche, InterMune and Pharmasset Announce Initiation of INFORM-1, the First Dual-Combination Clinical Trial with Oral Antivirals in Hepatitis C
9. InterMune to Report Top-Line Results of Triple Combination Study of ITMN-191 in January 2009
10. InterMune to Conduct Conference Call and Webcast to Discuss Results of Triple Combination Study of ITMN-191
11. InterMune to Announce Results of Phase 3 CAPACITY Program of Pirfenidone in IPF Tomorrow, February 3
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/3/2016)... 2016   Diplomat Pharmacy, Inc. (NYSE: DPLO) announced today that it is celebrating Hepatitis Awareness ... two patients who tell their personal story and encourage those at risk to get tested ... Hepatitis C ... ... Diplomat Specialty Pharmacy (PRNewsFoto/Diplomat Pharmacy, Inc.) ...
(Date:5/3/2016)... , May 3, 2016 Intec ... a clinical-stage biopharmaceutical company, today announced the appointment of ... Regulatory Affairs. "Ms. Strauss-Levy has 15 years ... has established an outstanding track record, having supported the ... regulatory approval processes in the United States ...
(Date:5/2/2016)... , May 2, 2016 Kalorama Information noted ... Medical Records) market in a recent white paper.  The ... Increased physician usage, a growing market are among the ... in Kalorama,s report EMR 2016: The Market ... Kalorama,s seventh complete study of the EMR industry, and ...
Breaking Medicine Technology:
(Date:5/4/2016)... ... May 04, 2016 , ... Hight-Doland Insurance Agency’s new community ... up with Big Brothers Big Sisters of Southwest Louisiana to help provide positive mentoring ... . , Big Brothers Big Sisters of Southwest Louisiana has been helping to guide ...
(Date:5/4/2016)... ... May 04, 2016 , ... Dr. Elyson and Dr. Assili, ... surgery at their office. Wisdom tooth removal, a common dental procedure, is performed for ... often are improperly erupted, resulting in risks of complications. By providing wisdom tooth removal ...
(Date:5/4/2016)... ... May 04, 2016 , ... Natalie Jill is a well ... in preparation of the launch of her new book: Natalie Jill’s 7 Day Jump ... guide designed to jump start a new healthy lifestyle featuring simple recipes using MitoXcell’s ...
(Date:5/4/2016)... , ... May 04, 2016 , ... ... medical coding, billing and compliance. In upcoming months, AudioEducator has lined up some ... Every conference is designed to give complete compliance know-how and practical, easy-to-apply advice. ...
(Date:5/4/2016)... ... 2016 , ... With the stamp of approval from the United States Congress, ... Cancer Research Month. According to the American Cancer Society (2016) , this year ... in four Americans dying as a result. , With numbers as influential as such, ...
Breaking Medicine News(10 mins):